Follow
Kausik Kumar Ray
Kausik Kumar Ray
Professor of Public Health, Imperial College London
Verified email at imperial.ac.uk - Homepage
Title
Cited by
Cited by
Year
Heart disease and stroke statistics—2016 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 133 (4), e38-e360, 2016
60635*2016
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of …
F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, L Badimon, ...
European heart journal 41 (1), 111-188, 2020
53412020
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
Emerging Risk Factors Collaboration
The lancet 375 (9733), 2215-2222, 2010
49082010
Evolocumab and clinical outcomes in patients with cardiovascular disease
MS Sabatine, RP Giugliano, AC Keech, N Honarpour, SD Wiviott, ...
New England journal of medicine 376 (18), 1713-1722, 2017
45902017
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
BM Scirica, DL Bhatt, E Braunwald, PG Steg, J Davidson, B Hirshberg, ...
New England Journal of Medicine 369 (14), 1317-1326, 2013
38742013
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute …
JP Collet, H Thiele, E Barbato, O Barthélémy, J Bauersachs, DL Bhatt, ...
European heart journal 42 (14), 1289-1367, 2021
30522021
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
N Sattar, D Preiss, HM Murray, P Welsh, BM Buckley, AJM de Craen, ...
The Lancet 375 (9716), 735-742, 2010
29702010
Major lipids, apolipoproteins, and risk of vascular disease
R Assessment
Jama 302 (18), 1993-2000, 2009
27562009
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of …
BG Nordestgaard, MJ Chapman, SE Humphries, HN Ginsberg, L Masana, ...
European heart journal 34 (45), 3478-3490, 2013
25942013
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
Emerging Risk Factors Collaboration
The Lancet 375 (9709), 132-140, 2010
25292010
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European …
BA Ference, HN Ginsberg, I Graham, KK Ray, CJ Packard, E Bruckert, ...
European heart journal 38 (32), 2459-2472, 2017
23502017
Lipoprotein (a) as a cardiovascular risk factor: current status
BG Nordestgaard, MJ Chapman, K Ray, J Borén, F Andreotti, GF Watts, ...
European heart journal 31 (23), 2844-2853, 2010
19332010
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
KK Ray, SRK Seshasai, S Wijesuriya, R Sivakumaran, S Nethercott, ...
The Lancet 373 (9677), 1765-1772, 2009
17602009
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis
D Preiss, SRK Seshasai, P Welsh, SA Murphy, JE Ho, DD Waters, ...
Jama 305 (24), 2556-2564, 2011
17402011
Lipoprotein (a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality
Emerging Risk Factors Collaboration
JAMA: the journal of the American Medical Association 302 (4), 412, 2009
15582009
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with …
FLJ Visseren, F Mach, YM Smulders, D Carballo, KC Koskinas, M Bäck, ...
European heart journal 42 (34), 3227-3337, 2021
14822021
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
MJ Chapman, HN Ginsberg, P Amarenco, F Andreotti, J Borén, ...
European heart journal 32 (11), 1345-1361, 2011
14722011
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society consensus panel statement on assessment, aetiology and management
ES Stroes, PD Thompson, A Corsini, GD Vladutiu, FJ Raal, KK Ray, ...
European heart journal 36 (17), 1012-1022, 2015
13252015
C-reactive protein, fibrinogen, and cardiovascular disease prediction
Emerging Risk Factors Collaboration
New England Journal of Medicine 367 (14), 1310-1320, 2012
12042012
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on …
M Cuchel, E Bruckert, HN Ginsberg, FJ Raal, RD Santos, RA Hegele, ...
European heart journal 35 (32), 2146-2157, 2014
9582014
The system can't perform the operation now. Try again later.
Articles 1–20